MK

Mayuri Kunal Deshpande

Active Director Director DIN 11487214
DIN 11487214 First appointment Jan 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Mayuri Kunal Deshpande

Data last updated:

Mayuri Kunal Deshpande is a Director at Medspera Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11487214
Primary Designation Director
Industry Pharma
First Appointment 16 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Jan 20262026Active

Directorship timeline

Open interactive timeline →
Medspera Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mayuri Kunal Deshpande

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mayuri Kunal Deshpande

Mayuri Kunal Deshpande currently holds 1 directorship: Medspera Pharmaceuticals Private Limited (Director, since 16 Jan 2026).

Mayuri Kunal Deshpande was first appointed on 16 Jan 2026 as Director at Medspera Pharmaceuticals Private Limited.

The current boards of Mayuri Kunal Deshpande's companies include Manoj Vijayrao Gulhane (Medspera Pharmaceuticals Private Limited), Tushar Shamrao Zalke (Medspera Pharmaceuticals Private Limited), Vipin Shankarrao Chepurwar (Medspera Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available